Oral and dental management related to radiation therapy for head and neck cancer.
The clinical management of squamous cell carcinoma of the head and neck causes oral sequelae that can compromise patients' quality of life and necessitate abandonment or reduction of optimal therapeutic regimens, which in turn reduces the odds of long-term survival. Such sequelae can be prevented or at least better managed if dental and medical health care providers work together. It is therefore essential that dentists have an understanding of cancer therapy and a sound working knowledge of the prevention and management options for the oral sequelae of cancer treatment. This paper offers the dental team an overview of the consequences associated with radiotherapy, as well as a systematic overview of preventing or managing acute and chronic conditions before and during radiotherapy. In addition, it reviews considerations for continued treatment needs during the patient"s lifetime.
Hancock
Pamela J
PJ
Department of Oral Medicine, University of Washington, Seattle, USA.
Epstein
Joel B
JB
Sadler
Georgia Robins
GR
D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002180:Candidiasis, Oral / Q000188:drug therapy / Q000209:etiology; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy; D002710:Chlorhexidine / Q000627:therapeutic use; D016371:Cranial Irradiation / Q000009:adverse effects*; D017742:Dental Care for Chronically Ill; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D007571:Jaw Diseases / Q000517:prevention & control; D009061:Mouth Mucosa / Q000528:radiation effects*; D009910:Oral Hygiene; D010025:Osteoradionecrosis / Q000517:prevention & control; D011832:Radiation Injuries / Q000517:prevention & control; D013280:Stomatitis / Q000209:etiology; D014987:Xerostomia / Q000209:etiology
D000891:Anti-Infective Agents, Local; D000935:Antifungal Agents; D002710:Chlorhexidine